GOVERNMENT FUNDING:
Boon for Biodefense
Cellerant and Achaogen rack up millions in new contracts.
Two small California biotechs, Cellerant and Achaogen, have secured new multi-million dollar federal defense contracts to develop technologies for combating potential bioterrorism threats with clinical stage therapies.
San Carlos-based Cellerant won a five-year contract valued at $153 million with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA).
Read More